U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 205962

BIVALIRUDIN (BIVALIRUDIN)
250MG/VIAL
Marketing Status: Prescription
Active Ingredient: BIVALIRUDIN
Proprietary Name: BIVALIRUDIN
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 250MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A205962
Product Number: 001
Approval Date: Jul 27, 2018
Applicant Holder Full Name: EUGIA PHARMA SPECIALITIES LTD
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top